ORR 100%!国产三抗临床数据密集读出,TCE、NKCE、免疫检查点靶向三抗引领差异化竞争

医麦客
Nov 21, 2025

免费早鸟票,200 张限量领取2025 年 11 月 21 日医麦客新闻 eMedClub News近日,美国血液学会(ASH)官方公布了本次年会常规摘要内容。根据披露,信达生物、齐鲁制药将首次公布其三抗初步临床数据,天广实生物也将更新其三抗的最新进展。(推荐阅读1:ORR 最高达 100%!信达生物三抗 IBI3003 首披临床数据;推荐阅读2:齐鲁制药 GPRC5D/BCMA/CD3 三抗首个...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10